Initiator Pharma A/S
SSE:INIT.ST
8.08 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.023 | 0.038 | 0.022 | 0.009 | 0.008 | 0.011 | 0.008 | 0.001 |
| Gross Profit
| -0.023 | -0.038 | -0.022 | -0.009 | -0.008 | -0.011 | -0.008 | -0.001 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0.015 | 0.026 | 0.012 | 0.005 | 0.006 | 0.009 | 0.006 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0.004 | 0.003 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0 |
| Other Expenses
| 0 | 3.315 | 1.446 | 1.232 | 0.973 | 1.174 | 1.381 | 0.187 |
| Operating Expenses
| 0.004 | 3.315 | 1.446 | 1.232 | 0.973 | 1.174 | 1.381 | 0.187 |
| Operating Income
| -0.027 | -41.74 | -23.072 | -10.531 | -9.339 | -12.611 | -9.561 | -0.887 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -0.001 | -2.392 | -1.172 | 0.291 | -0.636 | -0.093 | -0.801 | -0.005 |
| Income Before Tax
| -0.028 | -44.132 | -24.244 | -10.24 | -9.975 | -12.704 | -10.362 | -0.892 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.005 | -5.677 | -3.18 | -1.543 | -1.687 | -2.406 | -1.78 | 0.012 |
| Net Income
| -0.023 | -38.455 | -21.064 | -8.697 | -8.288 | -10.298 | -8.582 | -0.892 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0 | -0.72 | -0.53 | -0.3 | -0.32 | -0.4 | -0.97 | -0.079 |
| EPS Diluted
| -0 | -0.72 | -0.53 | -0.3 | -0.32 | -0.4 | -0.97 | -0.079 |
| EBITDA
| -0.027 | -41.74 | -23.061 | -10.505 | -9.252 | -12.523 | -9.477 | -0.875 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |